Table 1 Anthropometric and demographic data, body composition, spirometric, clinical control of asthma, IPAQ, and medications use
From: Peripheral muscle strength and functional capacity in patients with moderate to severe asthma
Asthma (n = 20) | Control (n = 15) | |
|---|---|---|
Sex (M/F) | 6/14 | 1/14 |
Age (years) | 44 ± 6.0 | 39 ± 6.0 |
Weight (kg) | 79.4 ± 15.5 | 71.3 ± 18.5 |
Height (cm) | 162.0 ± 8.0 | 163.7 ± 8.6 |
BMI (kg/m2) | 31.1 ± 6.0 | 26.4 ± 7.6* |
PCM (kg) | 49.8 ± 9.3 | 46.8 ± 9.0 |
Water (%) | 44.9 ± 5.2 | 46.6 ± 5.3 |
Fat (%) | 38.4 ± 6.7 | 33.3 ± 8.2* |
FEV1 (% pred) | 65 ± 15 | 102 ± 16.8* |
ACQ | 1 (0–4,5) | |
IPAQ (MET.min) per week | ||
Inactive | 30% | 6.66%* |
Moderately active | 55% | 73,33%* |
Very active | 15% | 20% |
Medication, n (%) | ||
Inhaled corticosteroids (CI) | 12 (60) | - |
CI + short-term B-agonists | 6 (30) | - |
CI + oral corticosteroids | 2 (10) | - |